TRUH
VanEck Healthcare TruSector ETF
TRUH
VanEck Healthcare TruSector ETF
-
NAV$25.58
as of April 02, 2026 -
Performance since inception-0.65%
as of April 02, 2026 -
Total Net Assets$511.65K
as of April 02, 2026 -
Total Expense Ratio0.10%
-
Inception Date04/01/2026
About TRUH
VanEck Healthcare TruSector ETF (the “Fund”) is an actively managed ETF that seeks long-term capital appreciation by investing in securities of healthcare-related companies or instruments that provide exposure to healthcare-related companies.
Overview
Why TRUH
- TruSectors provides full market cap exposure unlike most existing sector funds
- Existing ETFs often underweight largest sector weightings causing deviation in performance
- Built to help asset allocators track sector benchmarks with greater precision
Performance
Performance History:
Average Annual Total Returns* (%)| 1 MO | 3 MO | YTD | 1 YR | 3 YR | 5 YR | 10 YR |
LIFE 04/01/26 |
|
|---|---|---|---|---|---|---|---|---|
| TRUH (NAV) | -- | -- | -- | -- | -- | -- | -- | -- |
| TRUH (Market Price) | -- | -- | -- | -- | -- | -- | -- | -- |
| MarketVector Top US Health Care Companies Index | -- | -- | -- | -- | -- | -- | -- | -- |
| 1 MO | 3 MO | YTD | 1 YR | 3 YR | 5 YR | 10 YR |
LIFE 04/01/26 |
|
|---|---|---|---|---|---|---|---|---|
| TRUH (NAV) | -- | -- | -- | -- | -- | -- | -- | -- |
| TRUH (Market Price) | -- | -- | -- | -- | -- | -- | -- | -- |
| MarketVector Top US Health Care Companies Index | -- | -- | -- | -- | -- | -- | -- | -- |
$-0.17
/
-0.65%
Fees
Holdings
Daily Holdings (%) as of 04/01/2026
|
Ticker
|
Holding Name |
% of Net Assets |
Identifier (FIGI)
|
Shares
|
Asset Class |
Market Value (US$) |
Notional Value |
|---|---|---|---|---|---|---|---|
|
LLY |
Eli Lilly & Co | 14.09 |
BBG000BNBDC2 |
76 |
Stock | 72,544 | -- |
|
JNJ |
Johnson & Johnson | 11.00 |
BBG000BMHYD1 |
232 |
Stock | 56,636 | -- |
|
ABBV |
Abbvie Inc | 7.10 |
BBG0025Y4RY4 |
170 |
Stock | 36,547 | -- |
|
MRK |
Merck & Co Inc | 5.63 |
BBG000BPD168 |
240 |
Stock | 29,002 | -- |
|
UNH |
Unitedhealth Group Inc | 4.68 |
BBG000CH5208 |
88 |
Stock | 24,110 | -- |
|
AMGN |
Amgen Inc | 3.57 |
BBG000BBS2Y0 |
52 |
Stock | 18,371 | -- |
|
TMO |
Thermo Fisher Scientific Inc | 3.46 |
BBG000BVDLH9 |
36 |
Stock | 17,803 | -- |
|
ABT |
Abbott Laboratories | 3.34 |
BBG000B9ZXB4 |
168 |
Stock | 17,200 | -- |
|
GILD |
Gilead Sciences Inc | 3.27 |
BBG000CKGBP2 |
120 |
Stock | 16,836 | -- |
|
ISRG |
Intuitive Surgical Inc | 3.07 |
BBG000BJPDZ1 |
34 |
Stock | 15,791 | -- |
|
PFE |
Pfizer Inc | 3.05 |
BBG000BR2B91 |
550 |
Stock | 15,703 | -- |
|
BMY |
Bristol-Myers Squibb Co | 2.35 |
BBG000DQLV23 |
196 |
Stock | 12,099 | -- |
|
DHR |
Danaher Corp | 2.22 |
BBG000BH3JF8 |
60 |
Stock | 11,447 | -- |
|
SYK |
Stryker Corp | 2.17 |
BBG000DN7P92 |
34 |
Stock | 11,200 | -- |
|
VRTX |
Vertex Pharmaceuticals Inc | 2.08 |
BBG000C1S2X2 |
24 |
Stock | 10,734 | -- |
|
MDT |
Medtronic Plc | 2.07 |
BBG000BNWG87 |
124 |
Stock | 10,671 | -- |
|
MCK |
Mckesson Corp | 2.03 |
BBG000DYGNW7 |
12 |
Stock | 10,468 | -- |
|
BSX |
Boston Scientific Corp | 1.73 |
BBG000C0LW92 |
144 |
Stock | 8,928 | -- |
|
CVS |
Cvs Health Corp | 1.72 |
BBG000BGRY34 |
122 |
Stock | 8,844 | -- |
|
REGN |
Regeneron Pharmaceuticals Inc | 1.51 |
BBG000C734W3 |
10 |
Stock | 7,773 | -- |
|
HCA |
Hca Healthcare Inc | 1.48 |
BBG000QW7VC1 |
16 |
Stock | 7,596 | -- |
|
CI |
Cigna Group/The | 1.35 |
BBG00KXRCDP0 |
26 |
Stock | 6,950 | -- |
|
ELV |
Elevance Health Inc | 1.28 |
BBG000BCG930 |
22 |
Stock | 6,567 | -- |
|
COR |
Cencora Inc | 1.11 |
BBG000MDCQC2 |
18 |
Stock | 5,718 | -- |
|
ZTS |
Zoetis Inc | 0.91 |
BBG0039320N9 |
40 |
Stock | 4,692 | -- |
|
CAH |
Cardinal Health Inc | 0.91 |
BBG000D898T9 |
22 |
Stock | 4,664 | -- |
|
EW |
Edwards Lifesciences Corp | 0.88 |
BBG000BRXP69 |
56 |
Stock | 4,551 | -- |
|
IDXX |
Idexx Laboratories Inc | 0.88 |
BBG000BLRT07 |
8 |
Stock | 4,517 | -- |
|
BDX |
Becton Dickinson & Co | 0.85 |
BBG000BCZYD3 |
28 |
Stock | 4,378 | -- |
|
A |
Agilent Technologies Inc | 0.62 |
BBG000C2V3D6 |
28 |
Stock | 3,207 | -- |
|
GEHC |
Ge Healthcare Technologies Inc | 0.62 |
BBG01BFR8YV1 |
44 |
Stock | 3,167 | -- |
|
RMD |
Resmed Inc | 0.61 |
BBG000L4M7F1 |
14 |
Stock | 3,120 | -- |
|
WAT |
Waters Corp | 0.58 |
BBG000FQRVM3 |
10 |
Stock | 2,999 | -- |
|
IQV |
Iqvia Holdings Inc | 0.54 |
BBG00333FYS2 |
16 |
Stock | 2,758 | -- |
|
BIIB |
Biogen Inc | 0.50 |
BBG000C17X76 |
14 |
Stock | 2,573 | -- |
|
MTD |
Mettler-Toledo International Inc | 0.49 |
BBG000BZCKH3 |
2 |
Stock | 2,548 | -- |
|
DXCM |
Dexcom Inc | 0.46 |
BBG000QTF8K1 |
38 |
Stock | 2,370 | -- |
|
STE |
Steris Plc | 0.43 |
BBG00MRHG523 |
10 |
Stock | 2,199 | -- |
|
LH |
Labcorp Holdings Inc | 0.42 |
BBG01MMT6PL7 |
8 |
Stock | 2,182 | -- |
|
HUM |
Humana Inc | 0.41 |
BBG000BLKK03 |
12 |
Stock | 2,123 | -- |
|
DGX |
Quest Diagnostics Inc | 0.38 |
BBG000BN84F3 |
10 |
Stock | 1,977 | -- |
|
ZBH |
Zimmer Biomet Holdings Inc | 0.35 |
BBG000BKPL53 |
20 |
Stock | 1,821 | -- |
|
MRNA |
Moderna Inc | 0.33 |
BBG003PHHZT1 |
34 |
Stock | 1,701 | -- |
|
HOLX |
Hologic Inc | 0.32 |
BBG000C3NTN5 |
22 |
Stock | 1,663 | -- |
|
CNC |
Centene Corp | 0.30 |
BBG000BDXCJ5 |
46 |
Stock | 1,562 | -- |
|
VTRS |
Viatris Inc | 0.30 |
BBG00Y4RQNH4 |
112 |
Stock | 1,527 | -- |
|
WST |
West Pharmaceutical Services Inc | 0.29 |
BBG000BX24N8 |
6 |
Stock | 1,516 | -- |
|
INCY |
Incyte Corp | 0.29 |
BBG000BNPSQ9 |
16 |
Stock | 1,509 | -- |
|
-- |
Other | 0.25 |
-- |
18 |
other | 1,286 | -- |
|
PODD |
Insulet Corp | 0.24 |
BBG000R7XX87 |
6 |
Stock | 1,242 | -- |
|
UHS |
Universal Health Services Inc | 0.21 |
BBG000CB8Q50 |
6 |
Stock | 1,068 | -- |
|
ALGN |
Align Technology Inc | 0.20 |
BBG000BRNLL2 |
6 |
Stock | 1,036 | -- |
|
SOLV |
Solventum Corp | 0.17 |
BBG018YZH6T3 |
14 |
Stock | 901 | -- |
|
PKI |
Perkinelmer Inc | 0.17 |
BBG000FXW512 |
10 |
Stock | 879 | -- |
|
TECH |
Bio-Techne Corp | 0.17 |
BBG000C15114 |
16 |
Stock | 856 | -- |
|
BAX |
Baxter International Inc | 0.16 |
BBG000BCVJ77 |
50 |
Stock | 839 | -- |
|
HSIC |
Henry Schein Inc | 0.14 |
BBG000BNMMJ3 |
10 |
Stock | 730 | -- |
|
CRL |
Charles River Laboratories Internationa | 0.14 |
BBG000BG5BL8 |
4 |
Stock | 700 | -- |
|
DVA |
Davita Inc | 0.12 |
BBG000MQ1SN9 |
4 |
Stock | 601 | -- |
|
-USD CASH- |
0.00 |
-- |
0 |
Cash Bal | 0 | -- | |
|
-- |
Other/Cash | 0.00 |
-- |
0 |
Cash | 0 | -- |
Portfolio
Sector Weightings (%) as at 02/28/2026
-
Sector
% of Net Assets
Country Weightings (%) as at 02/28/2026
-
Country
% of Net Assets
Distributions
Yields as of 04/01/2026
Quarterly
0.00%
--
--
Distribution History
| Year | Ex-date |
Record Date |
Payable date |
Dividend Income‡ |
Short-Term Capital Gains |
Long-Term Capital Gains |
Return of Capital |
Total Distributions |
|---|
‡All registered investment companies are obliged to distribute portfolio gains to shareholders at yearend regardless of performance. Trading VanEck ETFs will also generate tax consequences and transaction expenses. The information provided is not intended to be tax advice. Tax consequences of dividend distributions may vary by individual taxpayer. There is no guarantee that dividends will be paid. To receive a distribution, you must have been a registered shareholder of the relevant VanEck ETFs on the record date. Distributions are paid to shareholders on the payment date. Past distributions are not indicative of future distributions.
Certain distributions may constitute a return of capital, which will have the effect of reducing your cost basis in the Fund’s shares and thereby increasing the amount of capital gain, if any, or decreasing the amount of capital loss, if any, that you will realize when selling or exchanging Fund shares. The final determination of the tax characteristics cannot be determined until after each Fund’s yearend and are reported to shareholders on Form 1099-DIV. The form is mailed to shareholders shortly after calendar yearend specifying how the distributions paid by the Fund during the prior calendar year should be characterized for purposes of reporting the distribution on a shareholder’s tax return.
The tax treatment and characterization of the Fund’s distributions may vary significantly from time to time depending on whether the Fund has gains or losses on the securities in its portfolio. The Fund’s distributions will normally reflect past and projected net investment income, and may include income from dividends and interest, capital gains and/or a return of capital. The final composition of the tax characteristics of the distributions cannot be determined with certainty until after the end of the year, and will be reported to shareholders at that time. The amount of distributions will vary, depending on a number of factors. As portfolio and market conditions change, the rate of dividends may change. There can be no assurance that the Fund will be able to declare a dividend distribution in each period. Past performance is no guarantee of future results.